Sarcura has won the LLB Banking Österreich Zukunft Award 2025
This prestigious recognition celebrates individuals and organizations driving sustainability, innovation, and social responsibility. It was awarded during an unforgettable evening at the breath taking Albertina, where 500 guests came together for LLB’s inspiring reception. A heartfelt thank you to Natalie Flatz and Robert Löw from LLB Banking Österreich for this incredible honor, as well as […]
Gradientechs distributör startar multicenterstudie på fyra sjukhus i Italien
Diagnostikföretaget Gradientech meddelar idag att a.d.a. SRL, bolagets exklusiva distributör för den italienska marknaden, inleder en multicenterstudie i Lombardiet-regionen med QuickMIC®. QuickMIC-systemet är utvecklat för ultrasnabb antibiotikaresistensbestämning (AST) av bakterier direkt från blodkulturprover. Multicenterstudien, som genomförs vid fyra sjukhus i Lombardiet-regionen i Milano-området, sker i samarbete med Italian Society for Clinical Microbiology (AMCLI) och syftar […]
Gradientech genomför en företrädesemission om cirka 60 MSEK
Styrelsen i Gradientech AB (publ) (”Gradientech” eller ”Bolaget”) beslutade den 17 december att genomföra en nyemission av aktier med företrädesrätt för befintliga aktieägare om cirka 60 MSEK (”Företrädesemissionen”). Ett prospekt avseende Företrädesemissionen har idag godkänts av Finansinspektionen och finns tillgängligt på Bolagets hemsida gradientech.se (https://gradientech.se/investerare-sv/foretradesemission-2025). Investerarpresentation den 22 januari 2025Aktieägare är välkomna att delta vid Gradientechs […]
ResoTher Pharma initiates dosing in its Phase 2a clinical trial in myocardial infarction patients
ResoTher Pharma is pleased to announce that the first patient has been dosed in the Phase 2a clinical trial of its novel drug candidate, RTP-026, in patients suffering from myocardial infarction (MI), commonly known as a heart attack. This significant milestone underscores ResoTher Pharma’s commitment to develop groundbreaking treatments for cardiovascular diseases. The Phase 2a […]
Intelligent Implants completes €6,2M first tranche of Series-A
Intelligent Implants, a Sweden-based MedTech startup, founded with a vision to transform orthopedic implants, proudly announces the successful closing of its Series A first tranche. The total capital in the first tranche is €6,2M (including conversion of convertible debt). This marks a significant milestone in its journey to revolutionize orthopedic implants. Intelligent Implants Series A […]
Dr Magnus Nilsson joins Intelligent Implants board of directors
Magnus is an exceptionally experienced medtech entrepreneur and executive with a stellar track record of building highly successful medtech companies responsible for improving outcomes for patients all over the world. Magnus is former CEO of Vitrolife, a highly profitable Swedish large cap medtech company providing fertility solutions to mothers throughout the globe. In addition, he […]
Sigrid Therapeutics Secures U.S. Market Access for SiPore® Technology Following SHINE Prediabetes Study Success
Stockholm, Sweden, March 10, 2025 – Sigrid Therapeutics (Sigrid) is excited to announce that it has secured U.S. market access for its proprietary SiPore® technology, following the success of the SHINE study, the largest of its kind in prediabetes. The study demonstrated that Carb Fence™, a medical-grade, fast-acting liquid formula powered by SiPore®, effectively reduces long-term […]
Texray AB, a pioneering developer of groundbreaking radiation protection textiles, is pleased to announce the filing of its tenth patent family, marking a significant milestone in Texray’s ongoing advancement of radiation protection solutions for medical professionals.
With a combination of granted patents covering both the revolutionary material platform and the commercialized, evidence-based products, along with newly filed applications, the intellectual property portfolio continues to strengthen and reinforcing Texray’s commitment to innovation in medical radiation safety. Recent patent applications introduce with the potential to impact the field of radiation protection shielding systems […]
Texray AB, the pioneering developer of a groundbreaking radiation protection textile, is proud to announce the appointment of Gregory Jump as Chief Commercial Officer (CCO) for the U.S. market.
With over 35 years of commercial healthcare experience at industry giants such as BIOTRONIK, GE Healthcare, Philips Healthcare, and Medtronic Inc., Jump brings a wealth of expertise to drive Texray’s expansion in the U.S. He is a recognized expert in medical devices, diagnostics, and diagnostic imaging, and has successfully introduced groundbreaking clinical technologies into complex […]
Sigrid Therapeutics i partnerskap med Kronans Apotek
Sigrid Stabiliser lanseras på Kronans Apotek – gör preventiv hälsa mer tillgänglig Stockholm, 5e februari 2025 – Sigrid Therapeutics meddelar idag att deras innovativa produkt, Sigrid Stabiliser, som tidigare endast funnits tillgänglig via företagets egen e-handel, nu kommer att lanseras och erbjudas exklusivt på Kronans Apotek med start i februari 2025. Partnerskapet innebär att […]
